Chicago Partners Investment Group’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.27M | Buy |
37,801
+552
| +1% | +$63.7K | 0.1% | 192 |
|
|
2025
Q4 | $4.03M | Buy |
37,249
+5,472
| +17% | +$514K | 0.1% | 183 |
|
|
2025
Q3 | $2.77M | Buy |
31,777
+2,218
| +8% | +$183K | 0.07% | 229 |
|
|
2025
Q2 | $2.48M | Buy |
29,559
+6,263
| +27% | +$498K | 0.07% | 227 |
|
|
2025
Q1 | $1.84M | Sell |
23,296
-3,907
| -14% | -$365K | 0.06% | 249 |
|
|
2024
Q4 | $2.72M | Buy |
27,203
+3,909
| +17% | +$403K | 0.09% | 184 |
|
|
2024
Q3 | $2.48M | Buy |
23,294
+289
| +1% | +$34.3K | 0.09% | 186 |
|
|
2024
Q2 | $2.65M | Buy |
23,005
+1,244
| +6% | +$160K | 0.1% | 169 |
|
|
2024
Q1 | $2.76M | Sell |
21,761
-1,465
| -6% | -$181K | 0.12% | 153 |
|
|
2023
Q4 | $2.76M | Sell |
23,226
-1,203
| -5% | -$125K | 0.13% | 145 |
|
|
2023
Q3 | $2.52M | Buy |
24,429
+5,813
| +31% | +$627K | 0.14% | 142 |
|
|
2023
Q2 | $1.97M | Buy |
18,616
+2,982
| +19% | +$339K | 0.1% | 190 |
|
|
2023
Q1 | $1.81M | Buy |
15,634
+1,822
| +13% | +$197K | 0.11% | 188 |
|
|
2022
Q4 | $1.46M | Buy |
13,812
+1,044
| +8% | +$107K | 0.09% | 210 |
|
|
2022
Q3 | $1.28M | Sell |
12,768
-677
| -5% | -$60.4K | 0.09% | 202 |
|
|
2022
Q2 | $1.2M | Buy |
13,445
+98
| +0.7% | +$8.69K | 0.09% | 203 |
|
|
2022
Q1 | $1.23M | Buy |
13,347
+429
| +3% | +$33.8K | 0.09% | 185 |
|
|
2021
Q4 | $988K | Buy |
12,918
+71
| +0.6% | +$5.66K | 0.07% | 221 |
|
|
2021
Q3 | $1.08M | Buy |
12,847
+649
| +5% | +$49.4K | 0.08% | 212 |
|
|
2021
Q2 | $942K | Sell |
12,198
-2,017
| -14% | -$150K | 0.07% | 228 |
|
|
2021
Q1 | $1.05M | Buy |
14,215
+1,511
| +12% | +$111K | 0.09% | 194 |
|
|
2020
Q4 | $982K | Buy |
12,704
+598
| +5% | +$45.7K | 0.09% | 179 |
|
|
2020
Q3 | $889K | Buy |
12,106
+592
| +5% | +$46.4K | 0.11% | 153 |
|
|
2020
Q2 | $867K | Buy |
11,514
+272
| +2% | +$20.5K | 0.11% | 146 |
|
|
2020
Q1 | $895K | Sell |
11,242
-802
| -7% | -$63K | 0.14% | 122 |
|
|
2019
Q4 | $1.05M | Sell |
12,044
-42
| -0.3% | -$3.45K | 0.13% | 122 |
|
|
2019
Q3 | $952K | Buy |
12,086
+558
| +5% | +$44.7K | 0.13% | 116 |
|
|
2019
Q2 | $893K | Buy |
11,528
+306
| +3% | +$23.4K | 0.13% | 120 |
|
|
2019
Q1 | $784K | Sell |
11,222
-5,839
| -34% | -$437K | 0.12% | 128 |
|
|
2018
Q4 | $1.21M | Sell |
17,061
-6,783
| -28% | -$479K | 0.18% | 102 |
|
|
2018
Q3 | $1.63M | Buy |
23,844
+10,268
| +76% | +$654K | 0.24% | 73 |
|
|
2018
Q2 | $786K | Buy |
13,576
+7,584
| +127% | +$428K | 0.12% | 131 |
|
|
2018
Q1 | $311K | Sell |
5,992
-2,566
| -30% | -$139K | 0.05% | 210 |
|
|
2017
Q4 | $460K | Buy |
8,558
+2,934
| +52% | +$163K | 0.08% | 172 |
|
|
2017
Q3 | $344K | Buy |
5,624
+5,248
| +1,396% | +$318K | 0.06% | 201 |
|
|
2017
Q2 | $23K | Sell |
376
-4,491
| -92% | -$273K | 0.01% | 497 |
|
|
2017
Q1 | $295K | Buy |
4,867
+121
| +3% | +$7.34K | 0.08% | 150 |
|
|
2016
Q4 | $267K | Buy |
4,746
+102
| +2% | +$5.97K | 0.1% | 146 |
|
|
2016
Q3 | $277K | Buy |
4,644
+4,433
| +2,101% | +$259K | 0.11% | 143 |
|
|
2016
Q2 | $12K | Hold |
211
| – | – | 0.01% | 347 |
|
|
2016
Q1 | $11K | Hold |
211
| – | – | 0.01% | 337 |
|
|
2015
Q4 | $11K | Hold |
211
| – | – | 0.01% | 387 |
|
|
2015
Q3 | $10K | Hold |
211
| – | – | 0.01% | 333 |
|
|
2015
Q2 | $11K | Sell |
211
-2
| -0.9% | -$112 | 0.01% | 337 |
|
|
2015
Q1 | $12K | Sell |
213
-55
| -21% | -$3.11K | 0.01% | 333 |
|
|
2014
Q4 | $15K | Buy |
+268
| New | +$14.9K | 0.01% | 320 |
|
Other funds holding MRK
VCM
VPM
Chicago Partners Investment Group's MRK Position: Q1 2026 in Review
Chicago Partners Investment Group increased its Merck (MRK) stake by 1.5% in Q1 2026, buying an estimated $63.7K and bringing the position to 37,801 shares worth $4.27M. The position accounts for 0.1% of the portfolio, ranked #192.
Chicago Partners Investment Group first reported a position in MRK in Q4 2014 and has held it in 46 quarters since. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Chicago Partners Investment Group held 37,801 shares of Merck worth $4.27M as of Q1 2026.
- Chicago Partners Investment Group bought 552 Merck shares in Q1 2026, an estimated $63.7K.
- Merck made up 0.1% of Chicago Partners Investment Group's portfolio in Q1 2026, its #192 holding.
- Chicago Partners Investment Group first reported a position in Merck in Q4 2014 and has held it in 46 quarters since.
- 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Chicago Partners Investment Group's 13F filing for Q1 2026, filed 4 May 2026.